HeartBeam, Inc. (NASDAQ:BEAT) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants Branislav Vajdic - Founder & Chief Executive Officer Robert Eno - President Richard Brounstein - Chief Financial Officer Conference Call Participants Ben Haynor - Alliance Global Partners Operator Greetings and welcome to the HeartBeam Second Quarter 2023 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. At this time, I'll turn the call ove ...

2118 Walsh Avenue, Suite 210 Santa Clara, CA Address of Principal Executive Offices Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐ If an emerging growth company, indicate by check mark if the registrant ...

HeartBeam, Inc. (NASDAQ:BEAT) Q1 2023 Earnings Conference Call May 11, 2023 6:00 PM ET Company Participants Branislav Vajdic - Founder and Chief Executive Officer Rob Eno - President Richard Brounstein - Chief Financial Officer Conference Call Participants Jason Kolbert - Dawson James William Sutherland - The Benchmark Company Ben Haynor - Alliance Global Partners Operator Greetings and welcome to the HeartBeam First Quarter 2023 Financial Results Conference Call. At this time all participants are in listen ...

Table of contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 or For the transition period from ___________ to ___________ HEARTBEAM, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 47-4881450 State or Other Jurisdiction of Incorporation or Organization I.R.S. Employer Identification No. 95050 ZipCode Securities registered pursuant to Section 12(b) of the Act: ...

Medical Grade Heart Attack Detection Always with the patient mbe88 Fourth Quarter and Full Year 2022 Financial Results Conference Call NASDAQ: BEAT March 16, 2023 Fourth Quarter 2022 Financial Results Conference Call DISCLAIMERS This presentation contains forward-looking statements. All statements other than statements of historical fact contained in this presentation, including statements as to the Company's future results of operations and financial position, planned products and services, business strate ...

HeartBeam, Inc. (NASDAQ:BEAT) Q4 2022 Results Earnings Conference Call March 16, 2023 4:30 PM ET Company Participants Branislav Vajdic - Founder and Chief Executive Officer Robert Eno - President Richard Brounstein - Chief Financial Officer Conference Call Participants Jason Kolbert - Dawson James William Sutherland - The Benchmark Company Ben Haynor - Alliance Global Partners Operator Greetings. And welcome to the HeartBeam Fourth Quarter and Full-Year 2022 Financial Results Conference Call. At this time, ...

Net cash used in our operating activities of $3.2 million during the year ended December 31, 2021, was primarily due to our net loss of $4.4 million less $1.9 million in accretion expense related the convertible notes that converted to common stock at the IPO and $0.4 million in other non-cash expenses, offset by an increase of $1.1 million of net changes in operating assets and liabilities. ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Securities registered pursuant ...

HeartBeam, Inc. (NASDAQ:BEAT) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Branislav Vajdic – Founder and Chief Executive Officer Jon Hunt – Chief Business Officer Rick Brounstein – Chief Financial Officer Conference Call Participants Jason Kolbert – Dawson James Bill Sutherland – The Benchmark Company Operator Greetings, and welcome to the HeartBeam Third Quarter 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode. A questio ...

Heart Attack Detection ■ wood Third Quarter 2022 Financial Results Conference Call NASDAQ: BEAT November 10, 2022 Third Quarter 2022 Financial Results Conference Call DISCLAIMERS This presentation contains forward-looking statements. All statements other than statements of historical fact contained in this presentation, including statements as to the Company's future results of operations and financial position, planned products and services, business strategy and plans and objectives of management for futu ...

Table of contents Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock BEAT NASDAQ Warrants BEATW NASDAQ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to _____ ...